Does the media favor KRMD or DCTH?

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 1.34 beat Delcath Systems' score of 0.26 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Delcath Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor KRMD or BWAY?

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 1.34 beat Brainsway's score of 0.88 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Brainsway 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor KRMD or NPCE?

In the previous week, NeuroPace had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for NeuroPace and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat NeuroPace's score of 0.47 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeuroPace 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor SGHT or KRMD?

In the previous week, Sight Sciences had 3 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Sight Sciences and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat Sight Sciences' score of 0.26 indicating that KORU Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sight Sciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

KORU Medical Systems (KRMD) Competitors

$3.23 +0.01 (+0.31%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$3.13 -0.10 (-3.07%)

As of 09/18/2026 07:55 PM Eastern

Compare

KRMD vs. DCTH, BWAY, TCMD, NPCE, and SGHT

Should you buy KORU Medical Systems stock or one of its competitors? KORU Medical Systems's main competitors and comparable companies include Delcath Systems (DCTH), Brainsway (BWAY), Tactile Systems Technology (TCMD), NeuroPace (NPCE), and Sight Sciences (SGHT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does KORU Medical Systems compare to Delcath Systems?

KORU Medical Systems (NASDAQ:KRMD) and Delcath Systems (NASDAQ:DCTH) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

KORU Medical Systems has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market.

KORU Medical Systems currently has a consensus target price of $7.00, suggesting a potential upside of 116.72%. Delcath Systems has a consensus target price of $23.17, suggesting a potential upside of 43.80%. Given KORU Medical Systems' higher possible upside, equities research analysts clearly believe KORU Medical Systems is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Delcath Systems	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

Delcath Systems has a net margin of 0.56% compared to KORU Medical Systems' net margin of -4.03%. Delcath Systems' return on equity of 0.46% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Delcath Systems	0.56%	0.46%	0.42%

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 19.4% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 1.34 beat Delcath Systems' score of 0.26 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Delcath Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Delcath Systems has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.61	-$2.64M	-$0.04	N/A
Delcath Systems	$85.23M	6.56	$2.70M	$0.01	1,611.00

Summary

Delcath Systems beats KORU Medical Systems on 14 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to Brainsway?

KORU Medical Systems (NASDAQ:KRMD) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

KORU Medical Systems has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market. Comparatively, Brainsway has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market.

Brainsway has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.61	-$2.64M	-$0.04	N/A
Brainsway	$52.22M	10.48	$7.57M	$0.44	30.93

KORU Medical Systems currently has a consensus price target of $7.00, suggesting a potential upside of 116.72%. Brainsway has a consensus price target of $18.20, suggesting a potential upside of 33.73%. Given KORU Medical Systems' higher probable upside, research analysts plainly believe KORU Medical Systems is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Brainsway	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 19.0% of Brainsway shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Brainsway has a net margin of 15.65% compared to KORU Medical Systems' net margin of -4.03%. Brainsway's return on equity of 12.74% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Brainsway	15.65%	12.74%	8.17%

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 1.34 beat Brainsway's score of 0.88 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Brainsway	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Brainsway beats KORU Medical Systems on 12 of the 15 factors compared between the two stocks.

How does KORU Medical Systems compare to Tactile Systems Technology?

Tactile Systems Technology (NASDAQ:TCMD) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

Tactile Systems Technology has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

Tactile Systems Technology has a net margin of 7.10% compared to KORU Medical Systems' net margin of -4.03%. Tactile Systems Technology's return on equity of 11.49% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	7.10%	11.49%	9.17%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

In the previous week, KORU Medical Systems had 1 more articles in the media than Tactile Systems Technology. MarketBeat recorded 1 mentions for KORU Medical Systems and 0 mentions for Tactile Systems Technology. KORU Medical Systems' average media sentiment score of 1.34 beat Tactile Systems Technology's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Tactile Systems Technology	Neutral
KORU Medical Systems	Positive

Tactile Systems Technology presently has a consensus price target of $38.40, suggesting a potential upside of 72.97%. KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 116.72%. Given KORU Medical Systems' higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Tactile Systems Technology has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.53	$19.09M	$1.08	20.56
KORU Medical Systems	$41.13M	3.61	-$2.64M	-$0.04	N/A

Summary

Tactile Systems Technology beats KORU Medical Systems on 10 of the 15 factors compared between the two stocks.

How does KORU Medical Systems compare to NeuroPace?

KORU Medical Systems (NASDAQ:KRMD) and NeuroPace (NASDAQ:NPCE) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 19.2% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

KORU Medical Systems presently has a consensus target price of $7.00, suggesting a potential upside of 116.72%. NeuroPace has a consensus target price of $19.33, suggesting a potential upside of 35.39%. Given KORU Medical Systems' higher probable upside, equities analysts plainly believe KORU Medical Systems is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

In the previous week, NeuroPace had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for NeuroPace and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat NeuroPace's score of 0.47 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeuroPace	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

KORU Medical Systems has a net margin of -4.03% compared to NeuroPace's net margin of -19.34%. KORU Medical Systems' return on equity of -10.63% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
NeuroPace	-19.34%	-105.64%	-16.51%

KORU Medical Systems has higher earnings, but lower revenue than NeuroPace. KORU Medical Systems is trading at a lower price-to-earnings ratio than NeuroPace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.61	-$2.64M	-$0.04	N/A
NeuroPace	$99.99M	4.90	-$21.47M	-$0.57	N/A

KORU Medical Systems has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market. Comparatively, NeuroPace has a beta of 1.94, suggesting that its share price is 94% more volatile than the broader market.

Summary

NeuroPace beats KORU Medical Systems on 10 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

Sight Sciences has a beta of 2.5, suggesting that its stock price is 150% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 30.4% of Sight Sciences shares are held by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Sight Sciences had 3 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Sight Sciences and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat Sight Sciences' score of 0.26 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sight Sciences	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

KORU Medical Systems has a net margin of -4.03% compared to Sight Sciences' net margin of -35.69%. KORU Medical Systems' return on equity of -10.63% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-35.69%	-43.39%	-22.86%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

KORU Medical Systems has lower revenue, but higher earnings than Sight Sciences. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$77.36M	5.71	-$38.43M	-$0.56	N/A
KORU Medical Systems	$41.13M	3.61	-$2.64M	-$0.04	N/A

Sight Sciences currently has a consensus price target of $7.88, indicating a potential downside of 1.81%. KORU Medical Systems has a consensus price target of $7.00, indicating a potential upside of 116.72%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

KORU Medical Systems beats Sight Sciences on 9 of the 16 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KRMD vs. The Competition

Export

Metric	KORU Medical Systems	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$148.36M	$5.55B	$7.24B	$13.19B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	-80.75	25.34	275.49	25.40
Price / Sales	3.61	72.49	646.01	89.45
Price / Cash	N/A	32.64	76.25	51.42
Price / Book	8.73	5.69	10.46	6.33
Net Income	-$2.64M	$151.55M	$3.49B	$358.33M
7 Day Performance	2.22%	0.66%	0.59%	1.12%
1 Month Performance	-1.22%	-3.33%	-1.74%	-2.39%
1 Year Performance	-22.36%	6.79%	18.13%	5.35%

KORU Medical Systems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KRMD KORU Medical Systems	3.6914 of 5 stars	$3.23 +0.3%	$7.00 +116.7%	-22.4%	$148.36M	$41.13M	N/A	73	Positive News High Trading Volume
DCTH Delcath Systems	2.783 of 5 stars	$16.17 -1.6%	$23.17 +43.3%	+39.6%	$570.45M	$85.23M	1,618.62	156
BWAY Brainsway	4.6425 of 5 stars	$13.46 -1.2%	$18.20 +35.2%	+76.0%	$548.03M	$52.22M	30.59	129
TCMD Tactile Systems Technology	3.4997 of 5 stars	$22.51 -0.3%	$38.40 +70.6%	+57.9%	$511.26M	$329.52M	20.84	1,086	Positive News
NPCE NeuroPace	3.2186 of 5 stars	$14.25 -2.3%	$19.50 +36.8%	+43.7%	$500.79M	$99.99M	N/A	220	News Coverage Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KRMD) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KORU Medical Systems (KRMD) Competitors

KRMD vs. DCTH, BWAY, TCMD, NPCE, and SGHT

How does KORU Medical Systems compare to Delcath Systems?

Summary

How does KORU Medical Systems compare to Brainsway?

Summary

How does KORU Medical Systems compare to Tactile Systems Technology?

Summary

How does KORU Medical Systems compare to NeuroPace?

Summary

How does KORU Medical Systems compare to Sight Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KORU Medical Systems (KRMD) Competitors

KRMD vs. DCTH, BWAY, TCMD, NPCE, and SGHT

How does KORU Medical Systems compare to Delcath Systems?

Which has more volatility & risk, KRMD or DCTH?

Do analysts prefer KRMD or DCTH?

Is KRMD or DCTH more profitable?

Do institutionals & insiders hold more shares of KRMD or DCTH?

Does the media favor KRMD or DCTH?

Which has higher valuation & earnings, KRMD or DCTH?

Summary

How does KORU Medical Systems compare to Brainsway?

Which has more risk and volatility, KRMD or BWAY?

Which has preferable earnings and valuation, KRMD or BWAY?

Do analysts prefer KRMD or BWAY?

Do institutionals and insiders hold more shares of KRMD or BWAY?

Is KRMD or BWAY more profitable?

Does the media favor KRMD or BWAY?

Summary

How does KORU Medical Systems compare to Tactile Systems Technology?

Which has more risk & volatility, TCMD or KRMD?

Is TCMD or KRMD more profitable?

Does the media prefer TCMD or KRMD?

Do analysts prefer TCMD or KRMD?

Do institutionals & insiders have more ownership in TCMD or KRMD?

Which has higher valuation and earnings, TCMD or KRMD?

Summary

How does KORU Medical Systems compare to NeuroPace?

Do institutionals & insiders hold more shares of KRMD or NPCE?

Do analysts recommend KRMD or NPCE?

Does the media favor KRMD or NPCE?

Is KRMD or NPCE more profitable?

Which has preferable earnings & valuation, KRMD or NPCE?

Which has more risk and volatility, KRMD or NPCE?

Summary

How does KORU Medical Systems compare to Sight Sciences?

Which has more risk & volatility, SGHT or KRMD?

Do insiders and institutionals believe in SGHT or KRMD?

Does the media favor SGHT or KRMD?

Is SGHT or KRMD more profitable?

Which has stronger earnings & valuation, SGHT or KRMD?

Do analysts recommend SGHT or KRMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools